By Michael Irving
August 08, 2022
A new injectable hydrogel has shown promise in preventing glioblastoma relapse after surgery by training the immune system to hunt down straggler cancer cells
VIEW 1 IMAGE
Glioblastoma is one of the most deadly forms of cancer, often returning with a vengeance after surgery to remove it. Researchers at the University of Wisconsin-Madison have now developed an immunity-boosting hydrogel that can be injected into the brain after surgery to clear out remaining cancer stem cells.